TCR2 THERAPEUTICS INC. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q2 2021 to Q1 2023

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Tcr2 Therapeutics Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q2 2021 to Q1 2023.
  • Tcr2 Therapeutics Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending March 31, 2023 was 39.2M shares, a 1.84% increase year-over-year.
  • Tcr2 Therapeutics Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 38.6M shares, a 1.83% increase from 2021.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 39.2M +708K +1.84% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-11
Q4 2022 38.6M Oct 1, 2022 Dec 31, 2022 10-K 2023-03-23
Q3 2022 38.6M +423K +1.11% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-08
Q2 2022 38.6M +391K +1.02% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-08
Q1 2022 38.5M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q3 2021 38.2M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 38.2M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.